Truist Financial Corp Care Dx, Inc. Transaction History

Truist Financial Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$16.06 - $26.39 $22,467 - $36,919	-1,399 Reduced 10.63%	11,756 $200,000
Q2 2022 Jul 22, 2022	SELL	$20.49 - $39.72 $106,711 - $206,861	-5,208 Reduced 28.36%	13,155 $283,000
Q1 2022 Apr 22, 2022	BUY	$28.19 - $46.6 $25,117 - $41,520	891 Added 5.1%	18,363 $679,000
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $1,112 - $1,987	27 Added 0.15%	17,472 $794,000
Q3 2021 Nov 05, 2021	SELL	$59.15 - $91.99 $9,878 - $15,362	-167 Reduced 0.95%	17,445 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$63.02 - $95.11 $41,341 - $62,392	656 Added 3.87%	17,612 $1.61 Million
Q1 2021 May 17, 2021	SELL	$57.62 - $95.6 $52,779 - $87,569	-916 Reduced 5.13%	16,956 $1.15 Million
Q4 2020 Nov 19, 2021	SELL	$41.43 - $77.09 $142,684 - $265,497	-3,444 Reduced 16.16%	17,872 $1.3 Million
Q4 2020 Feb 18, 2021	BUY	$41.43 - $77.09 $34,138 - $63,522	824 Added 4.02%	21,316 $1.55 Million
Q3 2020 Nov 13, 2020	BUY	$30.88 - $37.94 $30 - $37	1 Added 0.0%	20,492 $777,000
Q2 2020 Aug 14, 2020	BUY	$18.95 - $35.43 $126,074 - $235,715	6,653 Added 48.08%	20,491 $726,000
Q1 2020 May 15, 2020	BUY	$13.94 - $28.25 $192,901 - $390,923	13,838 New	13,838 $302,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.